Dance BioPharm Inc., IPO Research Information

Dance BioPharm Inc., IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Dance BioPharm Inc.,, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Dance BioPharm Inc.,	DNCE - NASDAQ	Withdrawn	$0.00	$0.00	TBD
Underwriter(s): Wells Fargo Securities, Stifel
Co-Manager(s): Oppenheimer, Roth Capital Partners
Industry:
Filing(s): Filed 2014-04-10

About Dance BioPharm Inc., (adapted from Dance BioPharm Inc., prospectus):
They are a biopharmaceutical company focused on the development of inhaled insulin products for the treatment of diabetes.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "DNCE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.